End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 THB | +0.69% | +1.40% | -7.64% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- With a 2024 P/E ratio at 25.82 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's enterprise value to sales, at 3.54 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.64% | 861M | B | ||
+20.68% | 84.31B | C+ | ||
-29.31% | 69.9B | B- | ||
+9.65% | 29.06B | C+ | ||
-8.63% | 17.38B | B | ||
+2.14% | 17.01B | A- | ||
+0.39% | 15.35B | A- | ||
+6.47% | 12.91B | B- | ||
+68.23% | 12.47B | C+ | ||
+6.43% | 12.26B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CHG Stock
- Ratings Chularat Hospital